Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
6.79
-0.40 (-5.56%)
At close: Jul 11, 2025, 4:00 PM
6.90
+0.11 (1.62%)
After-hours: Jul 11, 2025, 5:47 PM EDT

DAWN Stock Forecast

Stock Price Forecast

The 7 analysts that cover DAWN stock have a consensus rating of "Strong Buy" and an average price target of $31.57, which forecasts a 364.95% increase in the stock price over the next year. The lowest target is $25 and the highest is $40.

Price Target: $31.57 (+364.95%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $25 $31.57 $32 $40
Change +268.19% +364.95% +371.28% +489.10%
* Price targets were last updated on May 7, 2025.

Analyst Ratings

The average analyst rating for DAWN stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Feb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy 444444
Buy 333333
Hold 100000
Sell 000000
Strong Sell 000000
Total 877777

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Needham
Needham
Strong Buy
Maintains
$30$27
Strong Buy Maintains $30$27 +297.64% May 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$36
Strong Buy Reiterates $36 +430.19% Apr 3, 2025
Goldman Sachs
Goldman Sachs
Strong Buy
Maintains
$39$27
Strong Buy Maintains $39$27 +297.64% Mar 25, 2025
JP Morgan
JP Morgan
Buy
Maintains
$39$34
Buy Maintains $39$34 +400.74% Mar 5, 2025
Wedbush
Wedbush
Buy
Reiterates
$32
Buy Reiterates $32 +371.28% Feb 26, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
154.74M
from 131.16M
Increased by 17.98%
Revenue Next Year
231.34M
from 154.74M
Increased by 49.50%
EPS This Year
-1.41
from -1.02
EPS Next Year
-0.85
from -1.41
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
----131.16M154.74M231.34M382.66M
Revenue Growth
-----17.98%49.50%65.41%
EPS
-7.33-4.62-2.17-2.37-1.02-1.41-0.850.24
EPS Growth
--------
Forward PE
-------27.93
No. Analysts
-----11119
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 169.1M309.3M477.8M
Avg 154.7M231.3M382.7M
Low 136.2M167.7M255.5M

Revenue Growth

Revenue Growth 20252026202720282029
High
28.9%
99.9%
106.5%
Avg
18.0%
49.5%
65.4%
Low
3.9%
8.4%
10.4%

EPS Forecast

EPS 20252026202720282029
High -1.21-0.160.68
Avg -1.41-0.850.24
Low -1.51-1.62-0.13

EPS Growth

EPS Growth 20252026202720282029
High ---
Avg ---
Low ---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.